11 employees
GigaMune focus on T cell therapeutics for solid tumors.
2017
$300K
from 3 investors over 3 rounds
GigaMune raised undisclosed on November 1, 2022
Investors: Bioverge and Boost VC
GigaMune raised $300K on September 1, 2018
Investors: National Cancer Institute